Progress in preventing chemotherapy-induced nausea and vomiting.
Our understanding of the pathophysiology of emesis has improved over the past 2 decades, and we now have drugs that can prevent acute emesis in most patients. Prevention and treatment of the delayed and anticipatory forms of chemotherapy-induced emesis remain a challenge.
Markman
Maurie
M
The Cleveland Clinic Taussig Cancer Center, The Cleveland Clinic Foundation, Ohio 44195, USA. markmam@ccf.org
D000932:Antiemetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003907:Dexamethasone / Q000627:therapeutic use; D017829:Granisetron / Q000627:therapeutic use; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D009325:Nausea / Q000139:chemically induced / Q000517:prevention & control*; D018377:Neurotransmitter Agents / Q000502:physiology; D017294:Ondansetron / Q000627:therapeutic use; D011807:Quinolizines / Q000627:therapeutic use; D014839:Vomiting / Q000139:chemically induced / Q000517:prevention & control* / Q000523:psychology
D000932:Antiemetics; D000970:Antineoplastic Agents; D003907:Dexamethasone; D017829:Granisetron; D007211:Indoles; D018377:Neurotransmitter Agents; D017294:Ondansetron; D011807:Quinolizines; C060344:dolasetron